Merck : MRK

All Merck Articles

1088 Articles

Paul Ausick | Apr 9, 2014 at 4:01 PM EDT

The 4 Stocks That Inspired The Bounce

thinkstockApril 9, 2014: Markets opened higher on Wednesday and then got a jolt higher following the afternoon release of the…

Paul Ausick | Mar 26, 2014 at 9:05 AM EDT

Telecoms Liven Up Short Interest in Big Dividend Stocks

ThinkstockThe short interest data for the first two weeks of March is out, and the results among the top high-yield…

Trey Thoelcke | Mar 26, 2014 at 8:45 AM EDT

J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now

Wikimedia CommonsWith the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large…

Paul Ausick | Mar 25, 2014 at 4:01 PM EDT

The 4 Stocks That Charged the Market Higher

thinkstockMarch 25, 2014: Markets opened higher on Tuesday but dipped sharply in the late morning on weakness in consumer discretionary,…

Paul Ausick | Mar 24, 2014 at 4:01 PM EDT

The 4 Stocks That Pushed Stocks Lower on Monday

thinkstockMarch 24, 2014: Markets opened slightly higher on Monday but soon took a turn south and spent most of the…

Paul Ausick | Mar 21, 2014 at 4:01 PM EDT

The 5 Stocks That Sank Markets on Friday

thinkstockMarch 21, 2014: Markets opened higher on Friday but the Nasdaq sank quickly, bounced for a while, and finally settled…

Jon C. Ogg | Mar 21, 2014 at 10:30 AM EDT

Did Endocyte Just Become Buyout Bait?

Endocyte is trading like it is being acquired. This is proof that any biotech with great cancer drug news can…

Douglas A. McIntyre | Mar 21, 2014 at 6:38 AM EDT

Ten Huge Companies Dodged State Taxes for Five Years

States, often burdened by budget deficits that grew during the recession, are not getting tax receipts from some of America's…

Paul Ausick | Mar 12, 2014 at 11:20 AM EDT

Short Interest Generally Wanes in High-Yield Dividend Stocks

ThinkstockThe short interest data for the final two weeks of February is out, and the results are somewhat surprising when…

Trey Thoelcke | Mar 12, 2014 at 9:00 AM EDT

Low P/E High-Dividend Blue Chip Leaders to Buy Now

The pricier the stock market gets, the more important it is for investors to keep a close eye on what…

Trey Thoelcke | Mar 10, 2014 at 9:05 AM EDT

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the…

Trey Thoelcke | Feb 17, 2014 at 7:05 AM EST

Biotech Buyout Bolsters Novartis Cancer Portfolio

Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not…

Paul Ausick | Feb 5, 2014 at 8:20 AM EST

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to…

Jon C. Ogg | Feb 4, 2014 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, February 4, 2014.…

Paul Ausick | Feb 3, 2014 at 7:15 AM EST

Only Four Dow Stocks Post January Gains

The 30 stocks comprising the Dow Jones Industrial Average combined to post a loss of just over 4.5% in January.…

1 … 49 50 51 52 53 … 73

Merck : MRK

All Merck Articles

The 4 Stocks That Inspired The Bounce

Telecoms Liven Up Short Interest in Big Dividend Stocks

J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now

The 4 Stocks That Charged the Market Higher

The 4 Stocks That Pushed Stocks Lower on Monday

The 5 Stocks That Sank Markets on Friday

Did Endocyte Just Become Buyout Bait?

Ten Huge Companies Dodged State Taxes for Five Years

Short Interest Generally Wanes in High-Yield Dividend Stocks

Low P/E High-Dividend Blue Chip Leaders to Buy Now

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Biotech Buyout Bolsters Novartis Cancer Portfolio

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

Only Four Dow Stocks Post January Gains

Home Upgrades That Can Increase Resale Value

3 Dividend Stocks to Buy Before July Ends and Hold Forever

This Is America’s Worst Car Brand

10 Ways to Be Exempt From Medicaid's New 80-Hour Work Rule

She Sold Long-Held Stock at a Gain the Year After Her Husband Died. Her Filing Status Just Halved Her Medicare Premium Thresholds.

Home Upgrades That Can Increase Resale Value

3 Dividend Stocks to Buy Before July Ends and Hold Forever

Merck : MRK

All Merck Articles

The 4 Stocks That Inspired The Bounce

Telecoms Liven Up Short Interest in Big Dividend Stocks

J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now

The 4 Stocks That Charged the Market Higher

The 4 Stocks That Pushed Stocks Lower on Monday

The 5 Stocks That Sank Markets on Friday

Did Endocyte Just Become Buyout Bait?

Ten Huge Companies Dodged State Taxes for Five Years

Short Interest Generally Wanes in High-Yield Dividend Stocks

Low P/E High-Dividend Blue Chip Leaders to Buy Now

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Biotech Buyout Bolsters Novartis Cancer Portfolio

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

Only Four Dow Stocks Post January Gains

Home Upgrades That Can Increase Resale Value

3 Dividend Stocks to Buy Before July Ends and Hold Forever

This Is America’s Worst Car Brand

Featured Reads

10 Ways to Be Exempt From Medicaid's New 80-Hour Work Rule

She Sold Long-Held Stock at a Gain the Year After Her Husband Died. Her Filing Status Just Halved Her Medicare Premium Thresholds.